Table 1.
Characterization of drug-loaded LPNPs
Samples | Size (nm) | PDI | EE (%) | LE (%) | Zeta potential (mV) |
---|---|---|---|---|---|
DOX-LPNPs | 111±7 | 0.10±0.03 | 80.2±0.3 | 6.2±0.5 | −5.4±0.5 |
TPL-LPNPs | 108±6 | 0.09±0.03 | 71.3±0.4 | 2.9±0.3 | −15.7±1.5 |
DOX/TPL-1/0.2 | 120±5 | 0.12±0.04 | 75.5±0.5 (DOX) | 5.3±0.3 (DOX) | −9.7±0.8 |
58.3±0.4 (TPL) | 1.1±0.1 (TPL) |
Abbreviations: DOX, doxorubicin; EE, encapsulation efficiency; LE, loading efficiency; LPNPs, lipid–polymer hybrid nanoparticles; PDI, polydispersity index; TPL, triptolide.